Epoetin beta

From Wikipedia, the free encyclopedia
Jump to: navigation, search
Epoetin beta
Clinical data
AHFS/Drugs.com International Drug Names
  • (Prescription only)
Identifiers
 YesY
B03XA01
UNII 64FS3BFH5W N
Chemical data
 N (what is this?)  (verify)

Epoetin beta (rINN) /ɛˈp.ɨtɨn/ is a synthetic, recombinant[1] form of erythropoietin. It stimulates erythropoiesis (increases red blood cell levels) and is used to treat anemia, commonly associated with chronic renal failure and cancer chemotherapy.

Epoetin is marketed under the trade names NeoRecormon.[2]

References[edit]

  1. ^ Dunn CJ, Markham A (1996). "Epoetin beta. A review of its pharmacological properties and clinical use in the management of anaemia associated with chronic renal failure". Drugs 51 (2): 299–318. doi:10.2165/00003495-199651020-00008. PMID 8808169. 
  2. ^ Amgen - Products. URL: http://www.amgen.com/patients/prca.html. Accessed on: October 21, 2007.

External links[edit]